Ipca Laboratories gets USFDA warning letter

For three of its manufacturing units

Ipca Laboratories announced that the United State Food and Drug Administration has issued a warning letter to the Company's manufacturing units at Ratlam (Madhva Pradesh), SEZ Indore (Pithampur) and Piparia (Silvassa).

The Company has already suspended shipments of its APIs and formulations for the US market till USFDA inspection observations are resolved. Therefore, since July 2014 the Company has not shipped any APIs or formulations to US market except the products which are exempted from the import alert.

Powered by Capital Market - Live News